Rifaximin



Rifaximin





(reh facks’ ah men)

XifaxanDNC

PREGNANCY CATEGORY C


Drug Classes

Antibiotic

Antidiarrheal


Therapeutic Actions

A structural analogue of rifampin; binds to bacterial DNA-dependent RNA polymerase and inhibits bacterial RNA synthesis. Ninety-seven percent passes through the GI tract unchanged; affects Escherichia coli in the GI tract; cause of most traveler’s diarrhea.


Indications



  • Treatment of patients 12 yr or older with traveler’s diarrhea caused by noninvasive strains of E. coli


  • Reduction of recurrence of hepatic encephalopathy in patients with advanced liver disease


  • Unlabeled uses: IBS, Clostridium difficile–associated diarrhea



Available Forms

TabletsDNC—200, 550 mg


Dosages

Adults and patients 12 yr and older



  • Traveler’s diarrhea: 200 mg PO tid for 3 days.

Adults



  • Hepatic encephalopathy: 550 mg PO bid.

Pediatric patients younger than 12 yr

Safety and efficacy not established.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 21, 2016 | Posted by in NURSING | Comments Off on Rifaximin

Full access? Get Clinical Tree

Get Clinical Tree app for offline access